ABSTRACT Heart rate, blood pressure, pulsus paradoxus, and cardiac output measured by means of transthoracic electrical impedance cardiography have been recorded in 29 children mean age 10 years ± 2 SD during status asthmaticus. Changes were recorded over the first two hours of treatment during which all patients received oxygen, intravenous fluid, and hydrocortisone, and were randomly assigned to receive aminophylline, salbutamol, or both. Admission values showed significant correlation of pulsus paradoxus with PaCO2 (r = 0 66). Pulsus paradoxus was greater than 20 mmHg for all patients with PaCo2 above 5 5 kPa. Mean stroke volume and cardiac output were 890% and 131 % of the resting convalescent values in the same children. Stroke volume cardiac output and heart rate did not correlate with peak expiratory flow rate or blood gas measurements. Aminophylline and salbutamol together were associated with significantly greater increase in PEF than aminophylline alone (p < 005). Nebulised salbutamol was just as effective as intravenous salbutamol. Heart rate and systolic blood pressure declined significantly after nebulised salbutamol and aminophylline, but not after intravenous salbutamol and aminophylline. Stroke volume and cardiac output did not change significantly in any treatment group.
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The disturbance of ventilatory function during severe acute asthma is associated with significant cardiovascular responses. Sinus tachycardia is almost always found,-4 though correlation with severity of illness is poor.1 4 Pulsus paradoxus increases with severity of asthma,35-reflecting a fall of pulse pressure and perhaps of stroke volume during inspiration. Permutt8 reported increased cardiac output in two adult volunteers during moderately severe asthma induced in the laboratory. There are no reports of the changes of cardiac output in children during severe asthma, but the finding of metabolic acidosis' suggests that oxygen supply to tissues may be inadequate. Arterial hypoxaemia which occurs frequently'-4 may account for the tissue hypoxia. Its effect would be compounded if cardiac output and tissue perfusion were reduced. We have measured heart rate, blood pressure, pulsus paradoxus, and cardiac output (Q) in a group of children at the time of admission to hospital for treatment of severe acute asthma. These measurements have been related to peak expiratory flow rate (PEF) and arterial blood gas measurements. The changes which occurred during the first two hours of treatment with aminophylline and a selective /2 stimulant salbutamol have also been measured to assess the comparative effectiveness of these drugs in the treatment of severe acute asthma in children.
Methods
The study was 16 , to 0 9 mg per kg per hour for patients 17 to 29. These increases were made as the plasma theophylline concentrations measured at the end of each study were below the therapeutic range of 10 to 20 ,ug per ml when the lower doses were used. Nebulised salbutamol was given as 2 5 mg (0 5 ml) of respirator solution diluted in 1-5 ml of saline via a Wright's nebuliser driven by oxygen at a 
Results
The data recorded on admission to the study are shown in table 1. Peak expiratory flow was less than or equal to 25 % of expected normal" in all subjects in whom it was measured. In one very distressed and uncooperative child initial measurement was impossible but PEF recorded immediately after initial treatment was 13 % of expected normal.
Arterial blood gas measurements were made in 26 admissions. Twenty-four samples were collected while the patients were breathing air and two while they were receiving oxygen via a face mask. Excluding the two patients receiving added oxygen, mean Pao2 was 8 kPa ±01 SE and mean Paco2 was 5 2 kPa ± 0'2 SE (Table 1) . Paco2 was greater than 5 5 kPa in 46% of patients. The reduction in PEF and the increase in pulsus paradoxus both correlated Edmunds, Godfrey Mean stroke volume was 37 ml per m2 + I SE and (table 2) . salbutamol during the second hour.
Heart rate of patients receiving aminophylline and nebulised salbutamol separately and in combination steadily slowed from 138 ± 3 SE at the time of admission to 122 ± 3 SE beats per minute during two hours of treatment (p < 0-001). There was no further change of mean heart rate among the 12 patients given a second dose of nebulised salbutamol after two hours. In contrast the mean heart rate of 14 patients given intravenous salbutamol alone and together with aminophylline (groups A/V, V/A and A + V) did not fall during treatment. After two hours their mean heart rate remained significantly higher than that of patients receiving nebulised salbutamol and aminophylline (fig 5 p < 0001) . Changes of heart rate among these 14 patients did not reach statistical significance, but large transient increases did occur in some individuals. Three of four patients who received aminophylline and intravenous salbutamol together (group A + V) had heart rates above 190 beats per minute for 15 minutes after the bolus doses had been given.
There was no significant overall change of stroke volume or cardiac output in any of the six treatment groups (table 3) . There were marked inter-subject differences in the responses observed. Change of cardiac output was more closely correlated with changes in stroke volume (r = 0-81, p < 0-001) than with change of heart rate (r = 0-43, p < 0001). Nebulised salbutamol and aminophylline caused little change, while bolus injection of intravenous salbutamol alone and together with aminophylline was followed by change of cardiac output ranging from -23 
